Health Care Deal News, December 23, 2013 - Valeant Pharmaceuticals International Made yet Another Acquisition Last Week, Last Week was a Busy one in the Pharmaceutical Space

 

Brought to you by www.DealSearchOnline.com
 

December 23, 2013 Issue:

 

Recent Health Care M&A Deals

Medical Devices

 

 

Acquirer

Target

Price

Valeant Pharmaceuticals

Solta Medical

$250 million

Pharmaceuticals

 

 

Torrent Pharmaceuticals Limited

Domestic formulations business

$320 million

Grunenthal GmbH

EU Rights to ZALVISO

$30 million

Physician Medical Groups

 

 

MEDNAX, Inc.

Neonatology Center of Winchester, P.C.

N/A

Rehabilitation

 

 

U.S. Physical Therapy, Inc.

Physical therapy business

$36 million

 

Technology Deal of the Week
Valeant Pharmaceuticals International (NYSE: VRX) made yet another acquisition last week, as it added medical device maker Solta Medical (NASDAQ: SLTM) to its portfolio for $250 million. Solta’s aesthetic devices are a natural fit with Valeant’s facial injectibles, professional skin care products and physician-dispensed products. Piper Jaffray & Co. acted as financial advisor to Solta and Fenwick & West LLP acted as legal advisor. Skadden, Arps, Slate, Meagher & Flom LLP acted as legal advisor to Valeant. ......Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

Charted Territory
Last week was a busy one in the Pharmaceutical space, as 11 transactions were announced. Of the seven that disclosed prices, the grand total was $7.1 billion. Not bad for mid-December.


Pharmaceutical Deals Announced between Dec. 16 and Dec. 20, 2013

Acquirer

Target

Price

The Bayer Group

Algeta ASA

$2.9 billion

AstraZeneca plc

BMY’s global diabetes assets

$2.7 billion

Jazz Pharmaceuticals

Gentium

$1.0 billion

Almirall, SA

Aqua Pharmaceutical Holdings

$327 million

Endo Health Solutions

NuPathe, Inc.

$105 million

Depomed, Inc.

US rights to Cambia

$48.7 million

Grunenthal GmbH

EU rights to Zalviso

$30 million

Avista Capital Partners

Vertical/Trigen Holdings

n/a

Everett Laboratories

Quinnova Pharmaceuticals, LLC

n/a

OPKO Health, Inc.

Laboratorio Arama de Uruguay

n/a

Mylan, Inc.

Rights to LAMA respiratory drug

n/a

Source: The Health Care M&A News, December 2013

Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today

 

Services Deal of the Week
U.S. Physical Therapy, Inc. (NASDAQ: USPH) is on the acquisition trail this month. Last week the company announced it had paid $36 million for a 90% interest in an unidentified “physical therapy business” that includes 11 clinics and three on-site industrial client locations. This deal comes on the heels of a much smaller one announced on December 10, in which USPH paid $1.6 million for an unidentified physical therapy group with 12 clinics. ....Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

In the Pipeline

ViewRay Incorporated of Cleveland, Ohio, secured $30 million in funding from existing equity investors, Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and OrbiMed Advisors, as well as a new investor, Cowealth Medical Holding Co Ltd (TT: 4745). Debt financing was provided by Hercules Technology Growth Capital (NYSE: HTGC). The funds are intended to support the worldwide commercialization of the ViewRay system, designed to improve the accuracy of cancer treatments through a patented combination of simultaneous MRI and radiation therapy delivery. ..... Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

Biotech Showcase™ 2014, January 13 -15, San Francisco, CA

Biotech Showcase™ is one of the largest annual healthcare conferences where private and small- and mid-cap biotechnology companies have an opportunity to present to and meet with investors and biopharmaceutical executives from around the world.

Now in its sixth year, Biotech Showcase 2014 is expected to feature presentations by close to 250 public and private companies and attract more than 1,500 attendees. The event will run a full program of topical plenary sessions and workshops.

Biotech Showcase is co-produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of providing high quality business support services to the biotechnology industry.
 

For more information and to register visit this link.

 

Upcoming Interactive Webcast:
Build or Join an ACO—Don’t Let The Opportunity Pass You By!
Thursday, January 23, 2014, 1:00 pm ET            
A year ago, the Affordable Care Act directed doctors, hospitals, and other health-care providers—including long-term-care facilities—to coordinate care provided to Medicare patients through Accountable Care Organizations (ACOs). Timing can be tricky—urgent for post-acute care providers—and appropriate contracts are crucial. Go to http://www.levinassociates.com/conferences/1401-online-conference or call 800-248-1668 to register.

 

Around the Web in Health Care M&A...Click here to see more

 
Webcast Calendar...Click here to see more

 

Upcoming Conference Partnerships... Click here to see more